Cargando…
Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade
Chronic immunodeficiency virus infections are characterized by dysfunctional cellular and humoral antiviral immune responses. As such, immune modulatory therapies that enhance and/or restore the function of virus-specific immunity may protect from disease progression. Here, we investigate the safety...
Autores principales: | Velu, Vijayakumar, Titanji, Kehmia, Zhu, Baogong, Husain, Sajid, Pladevega, Annette, Lai, Lilin, Vanderford, Thomas H., Chennareddi, Lakshmi, Silvestri, Guido, Freeman, Gordon J., Ahmed, Rafi, Amara, Rama Rao |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2753387/ https://www.ncbi.nlm.nih.gov/pubmed/19078956 http://dx.doi.org/10.1038/nature07662 |
Ejemplares similares
-
PD-1 blockade following ART interruption enhances control of pathogenic SIV in rhesus macaques
por: Velu, Vijayakumar, et al.
Publicado: (2022) -
Tfh1 Cells in Germinal Centers During Chronic HIV/SIV Infection
por: Velu, Vijayakumar, et al.
Publicado: (2018) -
OA07-03. Influence of preexisting vaccinia immunity on a DNA/MVA SIV vaccine, decreased cellular immunity but enhanced control of a pathogenic SIV challenge
por: Kannanganat, S, et al.
Publicado: (2009) -
Estimating the contribution of the gut to plasma viral load in early SIV infection
por: Petravic, Janka, et al.
Publicado: (2013) -
Beyond Antibodies: B Cells and the OPG/RANK-RANKL Pathway in Health, Non-HIV Disease and HIV-Induced Bone Loss
por: Titanji, Kehmia
Publicado: (2017)